PMID: 9295302

Hipfner DR, Almquist KC, Leslie EM, Gerlach JH, Grant CE, Deeley RG, Cole SP
Membrane topology of the multidrug resistance protein (MRP). A study of glycosylation-site mutants reveals an extracytosolic NH2 terminus.
J Biol Chem. 1997 Sep 19;272(38):23623-30., [PubMed]
Sentences
No. Mutations Sentence Comment
61 ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:61:4
status: NEW
view ABCC1 p.Asn23Gln details
ABCC1 p.Asn71Gln
X
ABCC1 p.Asn71Gln 9295302:61:13
status: NEW
view ABCC1 p.Asn71Gln details
The N23Q and N71Q mutations were generated by a modification of the PCR-based megaprimer method (34). Login to comment
62 ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:62:4
status: NEW
view ABCC1 p.Asn23Gln details
ABCC1 p.Asn71Gln
X
ABCC1 p.Asn71Gln 9295302:62:13
status: NEW
view ABCC1 p.Asn71Gln details
The N23Q and N71Q mutations were generated by a modification of the PCR-based megaprimer method (34). Login to comment
63 ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:63:190
status: NEW
view ABCC1 p.Asn23Gln details
ABCC1 p.Asn71Gln
X
ABCC1 p.Asn71Gln 9295302:63:258
status: NEW
view ABCC1 p.Asn71Gln details
The first PCR was carried out on the pBluescript construct containing the BamHI fragment cloned in the EcoRI to HindIII orientation (5Ј 3 3Ј) using the M13 primer and either the N23Q (5Ј-C ACG TGG CAA ACC AGC AAC CCC GAC T-3Ј) or the N71Q (5Ј-A CCT CTC CAG AAA ACC AAA ACT GCC T-3Ј) mutagenic primer (substituted nucleotide positions underlined). Login to comment
64 ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:64:178
status: NEW
view ABCC1 p.Asn23Gln details
ABCC1 p.Asn71Gln
X
ABCC1 p.Asn71Gln 9295302:64:234
status: NEW
view ABCC1 p.Asn71Gln details
The first PCR was carried out on the pBluescript construct containing the BamHI fragment cloned in the EcoRI to HindIII orientation (59 3 39) using the M13 primer and either the N23Q (59-C ACG TGG CAA ACC AGC AAC CCC GAC T-39) or the N71Q (59-A CCT CTC CAG AAA ACC AAA ACT GCC T-39) mutagenic primer (substituted nucleotide positions underlined). Login to comment
66 ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:66:4
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn1156Gln
X
ABCC1 p.Asn1156Gln 9295302:66:22
status: NEW
view ABCC1 p.Asn1156Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:66:10
status: NEW
view ABCC1 p.Asn1006Gln details
The N19Q, N1006Q, and N1156Q mutations were generated using the TransformerTM site-directed mutagenesis kit (CLONTECH Laboratories, Inc., Palo Alto, CA) based on the method developed by Deng and Nickoloff (35). Login to comment
67 ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:67:4
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:67:88
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn1156Gln
X
ABCC1 p.Asn1156Gln 9295302:67:22
status: NEW
view ABCC1 p.Asn1156Gln details
ABCC1 p.Asn1156Gln
X
ABCC1 p.Asn1156Gln 9295302:67:160
status: NEW
view ABCC1 p.Asn1156Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:67:10
status: NEW
view ABCC1 p.Asn1006Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:67:149
status: NEW
view ABCC1 p.Asn1006Gln details
The templates for mutagenesis were prepared by cloning the BamHI fragment as above (for N19Q) and the XmaI fragment (MRP nucleotides 2337-4322) (for N1006Q and N1156Q) from pcDNAI-MRP1 into pGEM®-3Z (Promega, Madison, WI). Login to comment
68 ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:68:88
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:68:135
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:68:292
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn1156Gln
X
ABCC1 p.Asn1156Gln 9295302:68:151
status: NEW
view ABCC1 p.Asn1156Gln details
ABCC1 p.Asn1156Gln
X
ABCC1 p.Asn1156Gln 9295302:68:160
status: NEW
view ABCC1 p.Asn1156Gln details
ABCC1 p.Asn1156Gln
X
ABCC1 p.Asn1156Gln 9295302:68:418
status: NEW
view ABCC1 p.Asn1156Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:68:144
status: NEW
view ABCC1 p.Asn1006Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:68:149
status: NEW
view ABCC1 p.Asn1006Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:68:350
status: NEW
view ABCC1 p.Asn1006Gln details
Mutagenesis was then performed according to the manufacturer`s instructions using the ScaI/ StuI and SspI/EcoRV selection primers (for N19Q and N1006Q/N1156Q mutations, respectively), and the following sense mutagenic oligonucleotide primers: 5Ј-C TGG GAC TGG CAG GTC ACG TGG-3Ј (N19Q), 5Ј-C CCC ATC GTC CAG GGG ACT CAG G-3Ј (N1006Q), and 5Ј-C TAT TCC CAT TTC CAG GAG ACC TTG C-3Ј (N1156Q). Login to comment
69 ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:69:4
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:69:72
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:69:135
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:69:280
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn1156Gln
X
ABCC1 p.Asn1156Gln 9295302:69:151
status: NEW
view ABCC1 p.Asn1156Gln details
ABCC1 p.Asn1156Gln
X
ABCC1 p.Asn1156Gln 9295302:69:382
status: NEW
view ABCC1 p.Asn1156Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:69:144
status: NEW
view ABCC1 p.Asn1006Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:69:326
status: NEW
view ABCC1 p.Asn1006Gln details
The N19Q/N23Q double mutant was also generated by this method using the N19Q mutagenic primer with the N23Q BamHI fragment in pGEM¾1;-3Z as a template. Login to comment
70 ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:70:4
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:70:72
status: NEW
view ABCC1 p.Asn19Gln details
The N19Q/N23Q double mutant was also generated by this method using the N19Q mutagenic primer with the N23Q BamHI fragment in pGEMt-3Z as a template. Login to comment
72 ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:72:4
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:72:93
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:72:14
status: NEW
view ABCC1 p.Asn1006Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:72:129
status: NEW
view ABCC1 p.Asn1006Gln details
The N19Q/N23Q/N1006Q triple mutant was prepared by cloning the BamHI fragment containing the N19Q/N23Q mutation into pcDNAI-MRP1/N1006Q. Login to comment
164 ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:164:31
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:164:37
status: NEW
view ABCC1 p.Asn23Gln details
ABCC1 p.Asn71Gln
X
ABCC1 p.Asn71Gln 9295302:164:47
status: NEW
view ABCC1 p.Asn71Gln details
Introduction of the individual N19Q, N23Q, and N71Q mutations in MSD1 did not result in a detectable alteration of the electrophoretic mobility of the intact proteins (Fig. 4A, lanes 3-5). Login to comment
165 ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:165:149
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:165:164
status: NEW
view ABCC1 p.Asn23Gln details
ABCC1 p.Asn71Gln
X
ABCC1 p.Asn71Gln 9295302:165:83
status: NEW
view ABCC1 p.Asn71Gln details
However, after digestion with trypsin, the N-2 fragments of wild-type MRP and MRP-(N71Q) co-migrated at 43-60 kDa, whereas the N-2 fragments of MRP-(N19Q) and MRP-(N23Q) migrated slightly faster at approximately 38-50 kDa (Fig. 4B, lanes 2-5). Login to comment
166 ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:166:9
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:166:24
status: NEW
view ABCC1 p.Asn23Gln details
The MRP-(N19Q) and MRP-(N23Q) N-2 fragments are glycosylated because they have lower electrophoretic mobility than the deglycosylated 25-kDa N-2 fragment of wild-type MRP (compare with Fig. 4B, lane 1). Login to comment
168 ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:168:93
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:168:98
status: NEW
view ABCC1 p.Asn23Gln details
To confirm that Asn19 and Asn23 are the only glycosylated sites in MSD1, we also produced an N19Q/N23Q MRP double mutant. Login to comment
169 ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:169:5
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:169:60
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:169:11
status: NEW
view ABCC1 p.Asn23Gln details
ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:169:66
status: NEW
view ABCC1 p.Asn23Gln details
ABCC1 p.Asn71Gln
X
ABCC1 p.Asn71Gln 9295302:169:76
status: NEW
view ABCC1 p.Asn71Gln details
MRP-(N19Q/ N23Q) migrated faster than wild-type MRP and the N19Q, N23Q, and N71Q single mutants (Fig. 4A, compare lane 6 with lanes 2-5). Login to comment
172 ABCC1 p.Asn1156Gln
X
ABCC1 p.Asn1156Gln 9295302:172:98
status: NEW
view ABCC1 p.Asn1156Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:172:81
status: NEW
view ABCC1 p.Asn1006Gln details
We next examined expression of the MSD3 glycosylation acceptor site mutants MRP-(N1006Q) and MRP-(N1156Q). Login to comment
173 ABCC1 p.Asn1156Gln
X
ABCC1 p.Asn1156Gln 9295302:173:9
status: NEW
view ABCC1 p.Asn1156Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:173:77
status: NEW
view ABCC1 p.Asn1006Gln details
The MRP-(N1156Q) mutant co-migrated with the wild-type protein, whereas MRP-(N1006Q) displayed a greater electrophoretic mobility (Fig. 4A, lanes 2, 7 and 8). Login to comment
174 ABCC1 p.Asn1156Gln
X
ABCC1 p.Asn1156Gln 9295302:174:54
status: NEW
view ABCC1 p.Asn1156Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:174:109
status: NEW
view ABCC1 p.Asn1006Gln details
The C-1 fragments derived from wild-type MRP and MRP-(N1156Q) also co-migrated, and the C-1 fragment of MRP-(N1006Q) had the same electrophoretic mobility as the PNGaseF-treated wild-type C-1 fragment (Fig. 4C, lanes 1-4). Login to comment
178 ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:178:168
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:178:174
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:178:224
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:178:230
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:178:257
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn19Gln
X
ABCC1 p.Asn19Gln 9295302:178:263
status: NEW
view ABCC1 p.Asn19Gln details
ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:178:174
status: NEW
view ABCC1 p.Asn23Gln details
ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:178:180
status: NEW
view ABCC1 p.Asn23Gln details
ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:178:229
status: NEW
view ABCC1 p.Asn23Gln details
ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:178:235
status: NEW
view ABCC1 p.Asn23Gln details
ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:178:262
status: NEW
view ABCC1 p.Asn23Gln details
ABCC1 p.Asn23Gln
X
ABCC1 p.Asn23Gln 9295302:178:268
status: NEW
view ABCC1 p.Asn23Gln details
ABCC1 p.Asn71Gln
X
ABCC1 p.Asn71Gln 9295302:178:180
status: NEW
view ABCC1 p.Asn71Gln details
ABCC1 p.Asn71Gln
X
ABCC1 p.Asn71Gln 9295302:178:186
status: NEW
view ABCC1 p.Asn71Gln details
ABCC1 p.Asn1156Gln
X
ABCC1 p.Asn1156Gln 9295302:178:198
status: NEW
view ABCC1 p.Asn1156Gln details
ABCC1 p.Asn1156Gln
X
ABCC1 p.Asn1156Gln 9295302:178:204
status: NEW
view ABCC1 p.Asn1156Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:178:186
status: NEW
view ABCC1 p.Asn1006Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:178:192
status: NEW
view ABCC1 p.Asn1006Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:178:267
status: NEW
view ABCC1 p.Asn1006Gln details
ABCC1 p.Asn1006Gln
X
ABCC1 p.Asn1006Gln 9295302:178:273
status: NEW
view ABCC1 p.Asn1006Gln details
A, crude membrane proteins from Cos-1 cells expressing wild-type MRP (WT) treated with (ϩ) or without (-) PNGase F, the single glycosylation site mutant MRP constructs N19Q, N23Q, N71Q, N1006Q, and N1156Q, the double mutant N19Q/N23Q, and the triple mutant N19Q/N23Q/N1006Q were separated by SDS-polyacrylamide gel electrophoresis on 5% gels and immunoblotted with mAb QCRL-1. Login to comment
231 ABCC1 p.Asn1156Gln
X
ABCC1 p.Asn1156Gln 9295302:231:49
status: NEW
view ABCC1 p.Asn1156Gln details
On the other hand, it was expected that the MRP-(N1156Q) mutant might be informative because this asparagine residue is predicted to be extracytoplasmic only in the MSD3 configurations with four transmembrane segments. Login to comment